A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Summary

Multi-center, randomized, double-blind, parallel-group study to confirm non-inferiority of KLH-2109 to Leuprorelin acetate in uterine fibroids patient with menorrhagia

Timeline

Start

2022-10-11

Primary completion

2024-08-21

Completion

2024-08-21

Publications

• Osuga Y, Harada T, Takahashi H, Kawai A, Shimamura F; KLH2301 Investigators. Linzagolix versus leuprorelin in Japanese women with uterine leiomyomas: a phase 3, randomized, active-controlled, non-inferiority trial. Hum Reprod. 2026 Jul 6:deag106. doi: 10.1093/humrep/deag106. Online ahead of print.

Drugs

Indications